• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二甲双胍联合用药可预防奥氮平引起的代谢功能障碍,并调节大鼠的肠道-肝脏轴。

Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats.

机构信息

Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.

Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, 410078, People's Republic of China.

出版信息

Psychopharmacology (Berl). 2021 Jan;238(1):239-248. doi: 10.1007/s00213-020-05677-8. Epub 2020 Oct 23.

DOI:10.1007/s00213-020-05677-8
PMID:33095288
Abstract

OBJECTIVE

Olanzapine is widely prescribed for patients with mental disorders; however, it may induce metabolic dysfunction. Metformin is an efficient adjuvant for preventing olanzapine-induced metabolic dysfunction in clinical practice. Although the mechanism of how metformin prevents this metabolic dysfunction remains unknown, changes in the gut-liver axis are considered a potential explanation.

METHODS

Forty-eight male rats were gavaged with olanzapine and/or metformin for 35 consecutive days. Body weight, food intake, and water intake were measured daily. Histopathological and biochemical tests were performed to evaluate the metabolic dysfunction. The 16S rRNA obtained from fecal bacterial DNA was assessed.

RESULTS

Olanzapine treatment increased the body weight, blood glucose and triglyceride levels, and the number of adipocytes in the liver. While coadministration of metformin, there was a dose-dependent reverse of the abnormal changes induced by olanzapine treatment. Both olanzapine and metformin treatments altered the composition of the gut microbiota. Bacteroides acidifaciens and Lactobacillus gasseri were possibly played a positive role in metformin-mediated olanzapine-induced metabolic dysfunction prevention.

CONCLUSION

Metformin prevented olanzapine-induced metabolic dysfunction and regulated the gut microbiota in a dose-dependent manner.

摘要

目的

奥氮平被广泛用于治疗精神障碍患者,但可能会引起代谢功能紊乱。在临床实践中,二甲双胍是一种预防奥氮平引起代谢功能紊乱的有效辅助药物。虽然二甲双胍预防这种代谢功能紊乱的机制尚不清楚,但人们认为肠道-肝脏轴的变化是一个潜在的解释。

方法

48 只雄性大鼠连续 35 天灌胃奥氮平和/或二甲双胍。每天测量体重、食物摄入量和水摄入量。进行组织病理学和生化测试以评估代谢功能紊乱。评估来自粪便细菌 DNA 的 16S rRNA。

结果

奥氮平治疗增加了体重、血糖和甘油三酯水平,以及肝脏中的脂肪细胞数量。而二甲双胍的共同给药,奥氮平治疗引起的异常变化呈剂量依赖性逆转。奥氮平和二甲双胍治疗均改变了肠道微生物群的组成。拟杆菌和戊糖乳杆菌可能在二甲双胍介导的奥氮平诱导的代谢功能紊乱预防中发挥积极作用。

结论

二甲双胍以剂量依赖的方式预防奥氮平引起的代谢功能紊乱并调节肠道微生物群。

相似文献

1
Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats.二甲双胍联合用药可预防奥氮平引起的代谢功能障碍,并调节大鼠的肠道-肝脏轴。
Psychopharmacology (Berl). 2021 Jan;238(1):239-248. doi: 10.1007/s00213-020-05677-8. Epub 2020 Oct 23.
2
Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats.二甲双胍、阿卡波糖和西格列汀单药治疗对 Zucker 糖尿病肥胖大鼠肠道微生物群的影响。
BMJ Open Diabetes Res Care. 2019 Sep 20;7(1):e000717. doi: 10.1136/bmjdrc-2019-000717. eCollection 2019.
3
Metformin attenuates antipsychotic-induced metabolic dysfunctions in MK801-induced schizophrenia-like rats.二甲双胍减轻 MK801 诱导的精神分裂症样大鼠抗精神病药物引起的代谢功能障碍。
Psychopharmacology (Berl). 2020 Aug;237(8):2257-2277. doi: 10.1007/s00213-020-05524-w. Epub 2020 Jun 25.
4
Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice.二甲双胍通过调节肠道微生物群改善肥胖老龄小鼠的代谢特征。
Gut Microbes. 2018 Mar 4;9(2):155-165. doi: 10.1080/19490976.2017.1405209. Epub 2018 Feb 13.
5
Metformin attenuated sepsis-related liver injury by modulating gut microbiota.二甲双胍通过调节肠道微生物群减轻脓毒症相关的肝损伤。
Emerg Microbes Infect. 2022 Dec;11(1):815-828. doi: 10.1080/22221751.2022.2045876.
6
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
7
Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiota.二甲双胍通过增加肠道微生物群中的 Lactobacillus sp. MF-1 来缓解小鼠的肝纤维化。
Biochim Biophys Acta Mol Basis Dis. 2023 Jun;1869(5):166664. doi: 10.1016/j.bbadis.2023.166664. Epub 2023 Mar 7.
8
An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from .一项整合粪便微生物组和代谢组学的研究揭示了.EtOAc 提取物通过宿主-微生物代谢轴对 2 型糖尿病大鼠的抗糖尿病作用
Oxid Med Cell Longev. 2020 May 27;2020:1805418. doi: 10.1155/2020/1805418. eCollection 2020.
9
Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain.长期肠道微生物失调是导致奥氮平引起体重增加的原因。
Microbiol Spectr. 2023 Aug 17;11(4):e0005823. doi: 10.1128/spectrum.00058-23. Epub 2023 Jun 1.
10
In vivo therapeutic effect of combination treatment with metformin and Scutellaria baicalensis on maintaining bile acid homeostasis.二甲双胍与黄芩联合治疗对维持胆汁酸稳态的体内治疗效果。
PLoS One. 2017 Sep 6;12(9):e0182467. doi: 10.1371/journal.pone.0182467. eCollection 2017.

引用本文的文献

1
Characterizing defective lipid metabolism in the lateral septum of mice treated with olanzapine: implications for its side effects.奥氮平治疗小鼠侧隔核脂质代谢缺陷的特征:对其副作用的影响
Front Pharmacol. 2024 Jun 14;15:1419098. doi: 10.3389/fphar.2024.1419098. eCollection 2024.
2
Rat microbial biogeography and age-dependent lactic acid bacteria in healthy lungs.健康肺中大鼠微生物区系及其与年龄相关的乳酸菌。
Lab Anim (NY). 2024 Feb;53(2):43-55. doi: 10.1038/s41684-023-01322-x. Epub 2024 Jan 31.
3
Are probiotics effective in reducing the metabolic side effects of psychiatric medication? A scoping review of evidence from clinical studies.

本文引用的文献

1
Metformin attenuates antipsychotic-induced metabolic dysfunctions in MK801-induced schizophrenia-like rats.二甲双胍减轻 MK801 诱导的精神分裂症样大鼠抗精神病药物引起的代谢功能障碍。
Psychopharmacology (Berl). 2020 Aug;237(8):2257-2277. doi: 10.1007/s00213-020-05524-w. Epub 2020 Jun 25.
2
The gut-liver axis in liver disease: Pathophysiological basis for therapy.肝脏疾病中的肠-肝轴:治疗的病理生理学基础。
J Hepatol. 2020 Mar;72(3):558-577. doi: 10.1016/j.jhep.2019.10.003. Epub 2019 Oct 14.
3
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.
益生菌在减少精神药物的代谢副作用方面是否有效?来自临床研究的证据范围综述。
Transl Psychiatry. 2024 Jan 15;14(1):26. doi: 10.1038/s41398-024-02735-z.
4
Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain.长期肠道微生物失调是导致奥氮平引起体重增加的原因。
Microbiol Spectr. 2023 Aug 17;11(4):e0005823. doi: 10.1128/spectrum.00058-23. Epub 2023 Jun 1.
5
Clinical significance of microbiota changes under the influence of psychotropic drugs. An updated narrative review.精神药物影响下微生物群变化的临床意义。最新叙述性综述。
Front Microbiol. 2023 Mar 1;14:1125022. doi: 10.3389/fmicb.2023.1125022. eCollection 2023.
6
The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications.第二代抗精神病药物对脂质代谢的调节作用:肠道微生物群介导的潜在机制及治疗意义。
Front Pharmacol. 2023 Jan 25;14:1097284. doi: 10.3389/fphar.2023.1097284. eCollection 2023.
7
Mapping trends and hotspot regarding gastrointestinal microbiome and neuroscience: A bibliometric analysis of global research (2002-2022).胃肠道微生物群与神经科学的研究趋势和热点:全球研究的文献计量分析(2002 - 2022年)
Front Neurosci. 2022 Nov 17;16:1048565. doi: 10.3389/fnins.2022.1048565. eCollection 2022.
8
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review.精神分裂症与抗精神病药物引起的代谢改变中的肠道微生物群:一项范围综述
Ther Adv Psychopharmacol. 2022 May 15;12:20451253221096525. doi: 10.1177/20451253221096525. eCollection 2022.
9
Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy the AMPK-mTOR Signaling Pathway.二甲双胍通过激活自噬的AMPK-mTOR信号通路减轻二氧化硅诱导的肺纤维化。
Front Pharmacol. 2021 Aug 9;12:719589. doi: 10.3389/fphar.2021.719589. eCollection 2021.
32 种口服抗精神病药治疗反复发作性精神分裂症成人患者的急性疗效和耐受性的比较:系统评价和网络荟萃分析。
Lancet. 2019 Sep 14;394(10202):939-951. doi: 10.1016/S0140-6736(19)31135-3. Epub 2019 Jul 11.
4
Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis.二甲双胍对抗精神病药物所致代谢功能障碍的影响:肠-脑轴的潜在作用
Front Pharmacol. 2019 Apr 9;10:371. doi: 10.3389/fphar.2019.00371. eCollection 2019.
5
Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia.非典型抗精神病药物治疗和抗性淀粉补充对双相情感障碍或精神分裂症患者队列肠道微生物组组成的影响。
Pharmacotherapy. 2019 Feb;39(2):161-170. doi: 10.1002/phar.2214. Epub 2019 Feb 3.
6
Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population.中国人抗精神病药引起体重增加的药物遗传学相关性研究。
Neurosci Bull. 2019 Jun;35(3):561-580. doi: 10.1007/s12264-018-0323-6. Epub 2019 Jan 3.
7
The IRS/PI3K/Akt signaling pathway mediates olanzapine-induced hepatic insulin resistance in male rats.IRS/PI3K/Akt 信号通路介导奥氮平诱导雄性大鼠的肝胰岛素抵抗。
Life Sci. 2019 Jan 15;217:229-236. doi: 10.1016/j.lfs.2018.12.015. Epub 2018 Dec 12.
8
Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome.第二代抗精神病药物与代谢改变:肠道微生物组作用的系统评价。
Psychopharmacology (Berl). 2019 May;236(5):1491-1512. doi: 10.1007/s00213-018-5102-6. Epub 2018 Nov 20.
9
Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis.非典型抗精神病药物奥氮平会扰乱肝脏脂质代谢和主动脉炎症,并加重动脉粥样硬化。
Cell Physiol Biochem. 2018;50(4):1216-1229. doi: 10.1159/000494573. Epub 2018 Oct 24.
10
Three structurally and functionally distinct β-glucuronidases from the human gut microbe .来自人体肠道微生物的三种结构和功能不同的β-葡萄糖醛酸酶
J Biol Chem. 2018 Nov 30;293(48):18559-18573. doi: 10.1074/jbc.RA118.005414. Epub 2018 Oct 9.